Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
17.50
0.00 (0.00%)
At close: Mar 13, 2026, 4:00 PM EDT
17.56
+0.06 (0.32%)
After-hours: Mar 13, 2026, 4:10 PM EDT

Company Description

Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States.

It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.

The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions.

In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services.

The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Progyny, Inc.
Progyny logo
CountryUnited States
Founded2008
IPO DateOct 25, 2019
IndustryHealthcare Plans
SectorHealthcare
Employees856
CEOPeter Anevski

Contact Details

Address:
1359 Broadway
New York, New York 10018
United States
Phone212 888 3124
Websiteprogyny.com

Stock Details

Ticker SymbolPGNY
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$13.00
CIK Code1551306
CUSIP Number74340E103
ISIN NumberUS74340E1038
Employer ID27-2220139
SIC Code8090

Key Executives

NamePosition
Peter Anevski CPAChief Executive Officer and Director
David J. Schlanger J.D.Executive Chairman
Mark S. Livingston CPAChief Financial Officer
Allison SwartzExecutive Vice President, General Counsel and Secretary
Melissa B. CummingsChief Operating Officer
Steven LeistChief Technology Officer
James HartVice President of Investor Relations
Risa FisherChief Marketing Officer
Cassandra PrattChief Human Resources Officer
Julie StadlbauerChief Business Development Officer

Latest SEC Filings

DateTypeTitle
Mar 13, 20268-KCurrent Report
Mar 4, 2026144Filing
Mar 3, 2026144Filing
Mar 2, 2026144Filing
Feb 27, 2026S-8Securities to be offered to employees in employee benefit plans
Feb 27, 202610-KAnnual Report
Feb 26, 20268-KCurrent Report
Jan 12, 20268-KCurrent Report
Dec 17, 20258-KCurrent Report
Dec 11, 2025144Filing